Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
The national feature highlighted the story of Lindsey Rambo, the second participant in Opus Genetics’ ongoing Phase 1/2 trial of gene therapy OPGx-LCA5, aimed at restoring vision for people living ...
Opus Genetics (IRD) announced that its work was featured on Good Morning America in honor of World Blindness Awareness Month. The feature ...